• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

正常结肠上皮细胞在体外分泌尿激酶和纤溶酶原激活物抑制剂-1 。

Secretion of urokinase and plasminogen activator inhibitor-1 by normal colonic epithelium in vitro.

作者信息

Gibson P, Rosella O, Rosella G, Young G

机构信息

Department of Medicine, University of Melbourne, Royal Melbourne Hospital, Victoria, Australia.

出版信息

Gut. 1994 Jul;35(7):969-75. doi: 10.1136/gut.35.7.969.

DOI:10.1136/gut.35.7.969
PMID:8063226
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC1374846/
Abstract

Urokinase is a neutral protease whose major site of action is the external surface of the plasma membrane of cells and whose major function seems to be modulation of cell adhesion, such as that which occurs during cell migration. This study aimed to determine whether colonic epithelium is involved with the urokinase system. The contents of urokinase and one of its specific inhibitors, plasminogen activator inhibitor-1, were measured in culture supernatant and cell homogenates of isolated human colonic crypt cells. The amounts of both factors increased in supernatants over 24 hours, and approximately twice the amount was found in supernatants than in autologous cell homogenates. The secretion of both factors was similar in serum free and serum containing media. Northern blot analysis showed that messenger ribonucleic acid specific for urokinase and plasminogen activator inhibitor-1 was present in colonic crypt cells and that expression over 18 hours of culture was increased 12 fold for urokinase type plasminogen activator and two to fourfold for the inhibitor compared with values found in autologous freshly isolated cells. Urokinase activity was detected in crypt cell homogenates and supernatants indicating that it was present in excess of its inhibitors. Control experiments indicated that the epithelial cells themselves were responsible for the observations and excluded artefactual effects of the isolation procedure. In conclusion, isolated human colonic epithelial cells secrete urokinase and at least one of its specific inhibitors. Further investigation of the role of urokinase in the physiology and pathophysiology of colonic epithelium is indicated.

摘要

尿激酶是一种中性蛋白酶,其主要作用位点是细胞膜的外表面,其主要功能似乎是调节细胞黏附,比如在细胞迁移过程中发生的黏附。本研究旨在确定结肠上皮是否与尿激酶系统有关。在分离的人结肠隐窝细胞的培养上清液和细胞匀浆中测量了尿激酶及其一种特异性抑制剂——纤溶酶原激活物抑制剂-1的含量。两种因子的含量在24小时内的上清液中均增加,且在上清液中发现的量约为自体细胞匀浆中的两倍。在无血清和含血清培养基中,两种因子的分泌相似。Northern印迹分析表明,结肠隐窝细胞中存在尿激酶和纤溶酶原激活物抑制剂-1的特异性信使核糖核酸,并且与自体新鲜分离细胞中的值相比,培养18小时后尿激酶型纤溶酶原激活物的表达增加了12倍,抑制剂的表达增加了2至4倍。在隐窝细胞匀浆和上清液中检测到了尿激酶活性,表明其含量超过了抑制剂。对照实验表明,上皮细胞本身导致了这些观察结果,并排除了分离过程的人为影响。总之,分离的人结肠上皮细胞分泌尿激酶及其至少一种特异性抑制剂。提示需要进一步研究尿激酶在结肠上皮生理和病理生理中的作用。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6041/1374846/0755095d011a/gut00541-0116-b.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6041/1374846/e6d0ae4e13ad/gut00541-0116-a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6041/1374846/0755095d011a/gut00541-0116-b.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6041/1374846/e6d0ae4e13ad/gut00541-0116-a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6041/1374846/0755095d011a/gut00541-0116-b.jpg

相似文献

1
Secretion of urokinase and plasminogen activator inhibitor-1 by normal colonic epithelium in vitro.正常结肠上皮细胞在体外分泌尿激酶和纤溶酶原激活物抑制剂-1 。
Gut. 1994 Jul;35(7):969-75. doi: 10.1136/gut.35.7.969.
2
Butyrate is a potent inhibitor of urokinase secretion by normal colonic epithelium in vitro.丁酸盐在体外是正常结肠上皮细胞分泌尿激酶的有效抑制剂。
Gastroenterology. 1994 Aug;107(2):410-9. doi: 10.1016/0016-5085(94)90166-x.
3
Detection of mRNAs for urokinase-type plasminogen activator, its receptor, and type 1 inhibitor in giant cell tumors of bone with in situ hybridization.原位杂交检测骨巨细胞瘤中尿激酶型纤溶酶原激活剂、其受体及1型抑制剂的mRNA
Am J Pathol. 1995 Dec;147(6):1559-66.
4
Decreased plasminogen activator inhibitor-1 secretion in hypoxic corneal epithelial cells is associated with increased urokinase plasminogen activator activity.缺氧角膜上皮细胞中纤溶酶原激活物抑制剂-1分泌减少与尿激酶型纤溶酶原激活物活性增加有关。
Int J Biochem Cell Biol. 2003 Mar;35(3):339-48. doi: 10.1016/s1357-2725(02)00254-6.
5
Modulation of plasminogen activator inhibitor-1 and urokinase in retinal pigmented epithelial cells.视网膜色素上皮细胞中纤溶酶原激活物抑制剂-1和尿激酶的调节
Invest Ophthalmol Vis Sci. 1993 May;34(6):2055-61.
6
Urokinase plasminogen activator, uPa receptor, and its inhibitor in vernal keratoconjunctivitis.尿激酶型纤溶酶原激活剂、尿激酶型纤溶酶原激活剂受体及其抑制剂在春季角结膜炎中的作用
Invest Ophthalmol Vis Sci. 2005 Apr;46(4):1364-70. doi: 10.1167/iovs.04-1196.
7
Cell associated urokinase activity and colonic epithelial cells in health and disease.健康与疾病状态下细胞相关的尿激酶活性及结肠上皮细胞
Gut. 1991 Feb;32(2):191-5. doi: 10.1136/gut.32.2.191.
8
Oxygen modulates the release of urokinase and plasminogen activator inhibitor-1 by retinal pigment epithelial cells.氧气调节视网膜色素上皮细胞中尿激酶和纤溶酶原激活物抑制剂-1的释放。
Int J Biochem Cell Biol. 2001 Mar;33(3):237-47. doi: 10.1016/s1357-2725(01)00009-7.
9
Expression and localization of the urokinase-type plasminogen activator receptor (uPAR) in the human placenta.尿激酶型纤溶酶原激活物受体(uPAR)在人胎盘中的表达与定位
Kobe J Med Sci. 1998 Feb;44(1):31-43.
10
Plasminogen activator inhibitor type-2 (PAI-2) in human keratinocytes regulates pericellular urokinase-type plasminogen activator.人类角质形成细胞中的2型纤溶酶原激活物抑制剂(PAI-2)调节细胞周围尿激酶型纤溶酶原激活物。
Exp Cell Res. 1996 Feb 25;223(1):91-101. doi: 10.1006/excr.1996.0061.

引用本文的文献

1
Urokinase and the intestinal mucosa: evidence for a role in epithelial cell turnover.尿激酶与肠黏膜:上皮细胞更新作用的证据
Gut. 1998 Nov;43(5):656-63. doi: 10.1136/gut.43.5.656.
2
Colonic epithelium is diffusely abnormal in ulcerative colitis and colorectal cancer.在溃疡性结肠炎和结直肠癌中,结肠上皮存在弥漫性异常。
Gut. 1995 Jun;36(6):857-63. doi: 10.1136/gut.36.6.857.

本文引用的文献

1
Plasminogen activators and plasminogen activator inhibitors in human colorectal carcinoma tissues are not expressed by the tumour cells.人结直肠癌组织中的纤溶酶原激活剂和纤溶酶原激活剂抑制剂并非由肿瘤细胞表达。
Eur J Cancer. 1993;29A(8):1184-9. doi: 10.1016/s0959-8049(05)80312-0.
2
Location of plasminogen activator (PA) and PA inhibitor in human colorectal adenocarcinomas.
APMIS. 1993 Mar;101(3):235-41. doi: 10.1111/j.1699-0463.1993.tb00106.x.
3
A sensitive, coupled assay for plasminogen activator using a thiol ester substrate for plasmin.
Ann N Y Acad Sci. 1981;370:617-26. doi: 10.1111/j.1749-6632.1981.tb29768.x.
4
Crypt cell production rate in ulcerative proctocolitis: differential increments in remission and relapse.溃疡性直肠结肠炎中隐窝细胞生成率:缓解期和复发期的差异增量。
Gut. 1985 Oct;26(10):999-1003. doi: 10.1136/gut.26.10.999.
5
Localization of plasminogen activators in human colon cancer by immunoperoxidase staining.通过免疫过氧化物酶染色法对人结肠癌中纤溶酶原激活剂进行定位
Cancer Res. 1985 Apr;45(4):1787-96.
6
Protease nexins and cellular regulation.蛋白酶连接素与细胞调节
Semin Thromb Hemost. 1986 Jul;12(3):216-20. doi: 10.1055/s-2007-1003554.
7
A new colon carcinoma cell line (LIM1863) that grows as organoids with spontaneous differentiation into crypt-like structures in vitro.一种新的结肠癌细胞系(LIM1863),该细胞系在体外以类器官形式生长,并自发分化为隐窝样结构。
Cancer Res. 1987 May 15;47(10):2683-9.
8
Measurement of plasminogen activator inhibitor 1 in biologic fluids with a murine monoclonal antibody-based enzyme-linked immunosorbent assay.使用基于鼠单克隆抗体的酶联免疫吸附测定法测量生物流体中的纤溶酶原激活物抑制剂1
Blood. 1988 Jan;71(1):220-5.
9
Plasminogen activators in the intestine of patients with inflammatory bowel disease.
Thromb Haemost. 1988 Oct 31;60(2):262-6.
10
Distinct localizations of urokinase-type plasminogen activator and its type 1 inhibitor under cultured human fibroblasts and sarcoma cells.尿激酶型纤溶酶原激活剂及其1型抑制剂在培养的人成纤维细胞和肉瘤细胞下的不同定位。
J Cell Biol. 1987 Apr;104(4):1085-96. doi: 10.1083/jcb.104.4.1085.